ascopubs.org

NOHA: A Promising Biomarker for Determining Estrogen Receptor Status Among Patients With Breast Cancer in Resource-Constrained Settings

Building Capacity for Cancer Research in the Era of COVID-19: Implementation and Results From an International Virtual Clinical Research Training Program in Zambia Following informed consent, 70 newly ...
scmp.com

NOHA reels in big business under new ownership

Norway's largest supplier of fire fighting equipment is poised for stronger growth opportunities after Netherlands-based SK FireSafety Group acquired the company in October last year. Continuing to ...
ascopubs.org

NOHA: A sensitive, low-cost, and accessible blood-based biomarker to determine breast cancer estrogen receptor status in low-resource settings.

Three-year disease-free survival in randomized trials of chemotherapy and HER2-targeted therapy: A meta-analysis. Distinction in plasma NOHA between ER – and ER + breast cancer patients diagnosed with ...